普门科技：取得17α-羟孕酮测定试剂盒医疗器械注册证

Core Viewpoint - The company has received a medical device registration certificate for the 17α-hydroxyprogesterone assay kit, which is significant for diagnosing adrenal cortex diseases [1] Group 1: Product Registration - The product is classified as a Class II medical device and has a validity period until January 18, 2031 [1] - The assay kit is used for the quantitative measurement of 17α-hydroxyprogesterone levels in human serum [1] Group 2: Market Impact - The acquisition of the registration certificate enhances the company's portfolio of electrochemiluminescence assay products, increasing its market competitiveness [1] - The actual sales performance of the product post-launch will depend on market promotion efforts, making the future impact on the company's performance uncertain [1] Group 3: Company Achievements - As of the announcement date, the company and its subsidiaries have obtained 109 medical device registration certificates for electrochemiluminescence assay kits [1]